These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11181333)

  • 1. [Breast scintigraphy].
    Prats E; Razola P; García López F; Dolores Abós M; Banzo J
    Rev Esp Med Nucl; 2001 Feb; 20(1):47-70. PubMed ID: 11181333
    [No Abstract]   [Full Text] [Related]  

  • 2. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
    Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
    Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
    Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
    Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein.
    Ballinger JR
    Cancer Biother Radiopharm; 2001 Feb; 16(1):1-7. PubMed ID: 11279792
    [No Abstract]   [Full Text] [Related]  

  • 5. False positive of intramammary sentinel lymph node in lymphoscintigraphy.
    Lanchas Alfonso I; Miguel Martínez MB; García Higuera MI; Montero Ruiz JB; Aragón Martinez J; Duque Gallo JJ
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):161-2. PubMed ID: 21944192
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of axillary lymph node metastasis of breast carcinoma with technetium-99m sestamibi scintimammography.
    Tolmos J; Khalkhali I; Vargas H; Stuntz M; Cutrone J; Mishkin F; Diggles L; Venegas R; Klein S
    Am Surg; 1997 Oct; 63(10):850-3. PubMed ID: 9322655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scintimammography using Tc-99m tetrofosmin.
    Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
    Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of technetium-99m tetrofosmin mammoscintigraphy as compared to mammography for detecting and differentiating palpable breast masses of young Taiwanese women.
    Hoi YJ; Hsieh JF; Tsai SC; Sun SS; Kao CH
    Anticancer Res; 2000; 20(3B):2061-4. PubMed ID: 10928152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of Tc-99m MIBI related to tumour size and type.
    Buscombe JR; Cwikla JB; Thakrar DS; Hilson AJ
    Anticancer Res; 1997; 17(3B):1693-4. PubMed ID: 9179220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m tetrofosmin scintigraphy to evaluate breast lesions.
    Madariaga P; Almoguera I; Alonso A; Escat JL; Vegazo O; Martinez ML; Trampal C; Perez Vazquez JM
    Anticancer Res; 1997; 17(3B):1619-21. PubMed ID: 9179205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of bilateral multifocal breast cancer using Tc-99m sestamibi imaging. The role of delayed imaging.
    Derebek E; Balci P; Alanyali H; Kocdor MA; Capa G; Gorken IB; Degirmenci B; Alakavuklar M; Canda T; Durak H
    Clin Nucl Med; 1999 Aug; 24(8):590-3. PubMed ID: 10439180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of patient positioning in the detection of axillary lymphatic involvement with Tc-99m sestamibi scintimammography.
    Arslan N; Ozturk E; Ilgan S; Bayhan H
    Clin Nucl Med; 1999 Nov; 24(11):884-5. PubMed ID: 10551474
    [No Abstract]   [Full Text] [Related]  

  • 13. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer.
    Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC
    Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scintimammography with Tc-99m sestamibi.
    Khalkhali I; Iraniha S; Cutrone JA; Diggles LE; Klein SR
    Acta Med Austriaca; 1997; 24(2):46-9. PubMed ID: 9227786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the multidrug resistance P-glycoprotein: detection with technetium-99m-sestamibi in vivo.
    Luker GD; Fracasso PM; Dobkin J; Piwnica-Worms D
    J Nucl Med; 1997 Mar; 38(3):369-72. PubMed ID: 9074520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of quantification and visual analysis of the uptake of (99m)Tc-MIBI in the diagnosis of mammary lesions].
    Mulero F; Roca V; Nicolás F; Castellón I; Fuentes T; Abad L; Illana J; Nuño de la Rosa JA
    Rev Esp Med Nucl; 2000 Jun; 19(3):192-8. PubMed ID: 11062082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m-sestamibi uptake by recurrent Hurthle cell carcinoma of the thyroid.
    Balon HR; Fink-BennetT D; Stoffer SS
    J Nucl Med; 1992 Jul; 33(7):1393-5. PubMed ID: 1535374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [99m Tc-MIBI scintigraphy compared to mammography in the diagnosis of breast cancer in dense, operated and young women breasts].
    Mulero F; Nicolás F; Castellón MI; Fuentes T; de la Cruz P; Roca V; Abad L; Nuño de La Rosa JA
    Rev Esp Med Nucl; 2000 Sep; 19(5):344-9. PubMed ID: 11062110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer detection with sestamibi-Tc-99m and Tl-201 radionuclides in patients with non conclusive mammography.
    Alonso JC; Soriano A; Zarca MA; Guerra P; Alcazar R; Molino C
    Anticancer Res; 1997; 17(3B):1661-5. PubMed ID: 9179214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accessory breast cancer.
    Ohta H
    Ann Nucl Med; 2003 Jul; 17(5):358. PubMed ID: 12971632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.